<html xmlns:v="urn:schemas-microsoft-com:vml"
xmlns:o="urn:schemas-microsoft-com:office:office"
xmlns:w="urn:schemas-microsoft-com:office:word"
xmlns="http://www.w3.org/TR/REC-html40">

<head>
<meta http-equiv=Content-Type content="text/html; charset=windows-1252">
<meta name=ProgId content=Word.Document>
<meta name=Generator content="Microsoft Word 9">
<meta name=Originator content="Microsoft Word 9">
<link rel=File-List href="./Page2_files/filelist.xml">
<link rel=Edit-Time-Data href="./Page2_files/editdata.mso">
<!--[if !mso]>
<style>
v\:* {behavior:url(#default#VML);}
o\:* {behavior:url(#default#VML);}
w\:* {behavior:url(#default#VML);}
.shape {behavior:url(#default#VML);}
</style>
<![endif]-->
<title> </title>
<!--[if gte mso 9]><xml>
 <o:DocumentProperties>
  <o:Author>jennifer</o:Author>
  <o:Template>Normal</o:Template>
  <o:LastAuthor>jennifer</o:LastAuthor>
  <o:Revision>11</o:Revision>
  <o:TotalTime>27</o:TotalTime>
  <o:Created>2005-11-11T15:13:00Z</o:Created>
  <o:LastSaved>2005-11-11T18:45:00Z</o:LastSaved>
  <o:Pages>3</o:Pages>
  <o:Words>996</o:Words>
  <o:Characters>5679</o:Characters>
  <o:Company>EMBL-EBI</o:Company>
  <o:Lines>47</o:Lines>
  <o:Paragraphs>11</o:Paragraphs>
  <o:CharactersWithSpaces>6974</o:CharactersWithSpaces>
  <o:Version>9.6926</o:Version>
 </o:DocumentProperties>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <w:WordDocument>
  <w:Zoom>75</w:Zoom>
 </w:WordDocument>
</xml><![endif]-->
<style>
<!--
 /* Font Definitions */
@font-face
	{font-family:Wingdings;
	panose-1:5 0 0 0 0 0 0 0 0 0;
	mso-font-charset:2;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:0 268435456 0 0 -2147483648 0;}
 /* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
	{mso-style-parent:"";
	margin:0cm;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman";
	mso-fareast-font-family:"Times New Roman";}
h1
	{mso-style-next:Normal;
	margin-top:12.0pt;
	margin-right:0cm;
	margin-bottom:3.0pt;
	margin-left:0cm;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:1;
	font-size:16.0pt;
	font-family:Arial;
	mso-font-kerning:16.0pt;}
h2
	{mso-style-next:Normal;
	margin-top:12.0pt;
	margin-right:0cm;
	margin-bottom:3.0pt;
	margin-left:0cm;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:2;
	font-size:14.0pt;
	font-family:Arial;
	font-style:italic;}
h3
	{mso-style-next:Normal;
	margin:0cm;
	margin-bottom:.0001pt;
	text-align:justify;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:3;
	font-size:12.0pt;
	font-family:"Times New Roman";
	font-weight:normal;
	font-style:italic;}
p.MsoBodyTextIndent, li.MsoBodyTextIndent, div.MsoBodyTextIndent
	{margin:0cm;
	margin-bottom:.0001pt;
	text-align:justify;
	text-indent:36.0pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman";
	mso-fareast-font-family:"Times New Roman";}
a:link, span.MsoHyperlink
	{color:blue;
	text-decoration:underline;
	text-underline:single;}
a:visited, span.MsoHyperlinkFollowed
	{color:purple;
	text-decoration:underline;
	text-underline:single;}
@page Section1
	{size:595.3pt 841.9pt;
	margin:72.0pt 90.0pt 72.0pt 90.0pt;
	mso-header-margin:35.4pt;
	mso-footer-margin:35.4pt;
	mso-paper-source:0;}
div.Section1
	{page:Section1;}
 /* List Definitions */
@list l0
	{mso-list-id:899248372;
	mso-list-type:hybrid;
	mso-list-template-ids:16969764 67698699 67698691 67698693 67698689 67698691 67698693 67698689 67698691 67698693;}
@list l0:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0D8;
	mso-level-tab-stop:84.0pt;
	mso-level-number-position:left;
	margin-left:84.0pt;
	text-indent:-18.0pt;
	font-family:Wingdings;}
ol
	{margin-bottom:0cm;}
ul
	{margin-bottom:0cm;}
-->
</style>
</head>

<body lang=EN-GB link=blue vlink=purple style='tab-interval:36.0pt'>

<div class=Section1>

<p class=MsoNormal><a href="http://www.ebi.ac.uk/interpro/"
title="To the InterPro database"><span style='font-size:9.0pt;font-family:Arial;
color:black;text-decoration:none;text-underline:none'><!--[if gte vml 1]><v:shapetype
 id="_x0000_t75" coordsize="21600,21600" o:spt="75" o:preferrelative="t"
 path="m@4@5l@4@11@9@11@9@5xe" filled="f" stroked="f">
 <v:stroke joinstyle="miter"/>
 <v:formulas>
  <v:f eqn="if lineDrawn pixelLineWidth 0"/>
  <v:f eqn="sum @0 1 0"/>
  <v:f eqn="sum 0 0 @1"/>
  <v:f eqn="prod @2 1 2"/>
  <v:f eqn="prod @3 21600 pixelWidth"/>
  <v:f eqn="prod @3 21600 pixelHeight"/>
  <v:f eqn="sum @0 0 1"/>
  <v:f eqn="prod @6 1 2"/>
  <v:f eqn="prod @7 21600 pixelWidth"/>
  <v:f eqn="sum @8 21600 0"/>
  <v:f eqn="prod @7 21600 pixelHeight"/>
  <v:f eqn="sum @10 21600 0"/>
 </v:formulas>
 <v:path o:extrusionok="f" gradientshapeok="t" o:connecttype="rect"/>
 <o:lock v:ext="edit" aspectratio="t"/>
</v:shapetype><v:shape id="_x0000_i1025" type="#_x0000_t75" style='width:141pt;
 height:45pt'>
 <v:imagedata src="./Page2_files/image001.jpg" o:title="InterPro"/>
</v:shape><![endif]--><![if !vml]><img border=0 width=188 height=60
src="./Page2_files/image002.jpg" v:shapes="_x0000_i1025"><![endif]></span></a></p>

<h1 align=center style='text-align:center'><span style='font-size:28.0pt;
mso-bidi-font-size:16.0pt;color:navy'>Acetylcholine Receptors<o:p></o:p></span></h1>

<p class=MsoNormal><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<h2><span style='color:navy;font-style:normal'>Two Types of Receptors<o:p></o:p></span></h2>

<p class=MsoNormal><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<p class=MsoNormal style='text-align:justify;text-indent:36.0pt'>There are two
types of acetylcholine receptors (AChR) that bind acetylcholine and transmit
its signal: <span style="mso-spacerun: yes"> </span>muscarinic AChRs and
nicotinic AChRs, which are named after the agonists muscarine and nicotine,
respectively.<span style="mso-spacerun: yes">  </span>These receptors are
functionally different, the muscarinic type being G-protein coupled receptors
(GPCRs) that mediate a slow metabolic response via second messenger cascades,
while the nicotinic type are ligand-gated ion channels that mediate a fast
synaptic transmission of the neurotransmitter.<span style="mso-spacerun: yes"> 
</span></p>

<h2><span style='color:navy;font-style:normal'>Muscarinic Cholinergic Receptors<o:p></o:p></span></h2>

<p class=MsoNormal style='text-align:justify'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<table border=0 cellspacing=0 cellpadding=0 align=left style='border-collapse:
 collapse;mso-table-overlap:never;mso-table-lspace:9.05pt;mso-table-rspace:
 9.05pt;mso-table-anchor-vertical:paragraph;mso-table-anchor-horizontal:column;
 mso-table-left:left;mso-table-top:.05pt;mso-padding-alt:0cm 5.4pt 0cm 5.4pt'>
 <tr>
  <td width=215 style='width:161.6pt;background:#663300;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='text-align:justify;mso-element:frame;mso-element-frame-hspace:
  9.05pt;mso-element-wrap:auto;mso-element-anchor-vertical:paragraph;
  mso-element-anchor-horizontal:column;mso-element-top:.05pt;mso-height-rule:
  exactly'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>
  <p class=MsoNormal style='text-align:justify;mso-element:frame;mso-element-frame-hspace:
  9.05pt;mso-element-wrap:auto;mso-element-anchor-vertical:paragraph;
  mso-element-anchor-horizontal:column;mso-element-top:.05pt;mso-height-rule:
  exactly'><span style="mso-spacerun: yes"> </span><!--[if gte vml 1]><v:shape
   id="_x0000_i1026" type="#_x0000_t75" style='width:144.75pt;height:162pt'>
   <v:imagedata src="./Page2_files/image003.jpg" o:title="Amanita_muscaria_cropped"/>
  </v:shape><![endif]--><![if !vml]><img border=0 width=193 height=216
  src="./Page2_files/image004.jpg" v:shapes="_x0000_i1026"><![endif]><span
  style="mso-spacerun: yes">   </span></p>
  <p class=MsoNormal style='text-align:justify;mso-element:frame;mso-element-frame-hspace:
  9.05pt;mso-element-wrap:auto;mso-element-anchor-vertical:paragraph;
  mso-element-anchor-horizontal:column;mso-element-top:.05pt;mso-height-rule:
  exactly'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>
  </td>
  <td width=10 valign=top style='width:7.2pt;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='text-align:justify;mso-element:frame;mso-element-frame-hspace:
  9.05pt;mso-element-wrap:auto;mso-element-anchor-vertical:paragraph;
  mso-element-anchor-horizontal:column;mso-element-top:.05pt;mso-height-rule:
  exactly'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>
  </td>
 </tr>
 <tr>
  <td width=215 style='width:161.6pt;background:#FF9966;padding:0cm 5.4pt 0cm 5.4pt'>
  <h3 align=center style='text-align:center;mso-element:frame;mso-element-frame-hspace:
  9.05pt;mso-element-wrap:auto;mso-element-anchor-vertical:paragraph;
  mso-element-anchor-horizontal:column;mso-element-top:.05pt;mso-height-rule:
  exactly'><b>Amanita muscaria<o:p></o:p></b></h3>
  </td>
  <td width=10 valign=top style='width:7.2pt;padding:0cm 5.4pt 0cm 5.4pt'>
  <h3 align=center style='text-align:center;mso-element:frame;mso-element-frame-hspace:
  9.05pt;mso-element-wrap:auto;mso-element-anchor-vertical:paragraph;
  mso-element-anchor-horizontal:column;mso-element-top:.05pt;mso-height-rule:
  exactly'><![if !supportEmptyParas]>&nbsp;<![endif]><b><o:p></o:p></b></h3>
  </td>
 </tr>
</table>

<p class=MsoNormal style='text-align:justify;text-indent:36.0pt'>Muscarinic
receptors are characterised through their interaction with muscarine, a
water-soluble toxin derived from the mushroom <i>Amanita muscaria</i> that
causes substantial activation of the peripheral sympathetic nervous system
through its binding to muscarinic AChRs, resulting in convulsions and even
death.<span style="mso-spacerun: yes">  </span>The muscarinic AChRs occur
primarily in the CNS, and are part of a large family of G-protein-coupled
receptors (‘<a href="http://www.ebi.ac.uk/interpro/potm/2004_10/Page1.htm"
title="Protein of the Month">G proteins</a>’), which use an intracellular
secondary messenger system involving an increase of intracellular calcium to
transmit signals inside cells.<span style="mso-spacerun: yes">  </span>Binding
of acetylcholine to a muscarinic AChR causes a conformational change in the
receptor that is responsible for its association with and activation of an
intracellular G protein, the latter converting GTP to GDP in order to become
activated and dissociate from the receptor.<span style="mso-spacerun: yes"> 
</span>The activated G protein can then act as an enzyme to catalyse downstream
intracellular events.</p>

<p class=MsoNormal style='text-align:justify;text-indent:36.0pt'><span
style="mso-spacerun: yes">  </span>Muscarinic receptors are involved in a large
number of physiological functions including heart rate and force, contraction
of smooth muscles and the release of neurotransmitters.<span
style="mso-spacerun: yes">  </span>There are five subtypes of muscarinic AChRs based
on pharmacological activity:<span style="mso-spacerun: yes"> 
</span>M1-M5.<span style="mso-spacerun: yes">  </span>All five are found in the
CNS, while M1-M4 are also found in various tissues:<span style="mso-spacerun:
yes">  </span>M1 AChRs are common in secretory glands; M2 AChRs are found in
cardiac tissue; M3 AChRs are found in smooth muscles and in secretion glands.<span
style="mso-spacerun: yes">  </span>M1, M3 and M5 receptors cause the activation
of phospholipase C, generating two secondary messengers (IP3 and DAG)
eventually leading to an intracellular increase of calcium, while M2 and M4
inhibit adenylate cyclase, thereby decreasing the production of the second
messenger cAMP.<span style="mso-spacerun: yes">  </span>The activation of the
M2 receptor in the heart is important for closing calcium channels in order to
reduce the force and rate of contraction.<span style="mso-spacerun: yes"> 
</span></p>

<h2><span style='color:navy;font-style:normal'><br clear=all>
Nicotinic cholinergic receptors<o:p></o:p></span></h2>

<p class=MsoNormal><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<p class=MsoNormal style='text-align:justify'><span style='mso-tab-count:1'>            </span>Nicotinic
receptors are characterised through their interaction with nicotine in
tobacco.<span style="mso-spacerun: yes">  </span>The nicotinic AChRs are ligand-gated
ion channels that form pores in cells’ plasma membranes, mediating fast signal
transmission at synapses.<span style="mso-spacerun: yes">  </span>Nicotinic
AChRs are involved in a wide range of physiological processes, and can be
either neuronal or muscle-type.<span style="mso-spacerun: yes"> 
</span>Muscle-type nicotinic AChRs are localised at neuromuscular junctions,
where an electrical impulse from a neuron to a muscle cell signals contraction
and is responsible for muscle tone; as such, these receptors are targets for
muscle relaxants.<span style="mso-spacerun: yes">  </span>The many types of
neuronal nicotinic AChRs are located at synapses between neurons, such as in the
CNS where they are involved in cognitive function, learning and memory,
arousal, reward, motor control and analgesia.</p>

<p class=MsoNormal style='text-align:justify'><span style='mso-tab-count:1'>            </span>The
binding of acetylcholine to nicotinic AChRs brings about their activation.<span
style="mso-spacerun: yes">  </span>When two molecules of acetylcholine bind a
nicotinic AchR, a conformational change occurs in the receptor, resulting in
the formation of an ion pore.<span style="mso-spacerun: yes">  </span>At the
neuromuscular junction, the opening of a pore produces a rapid increase in the cellular
permeability of sodium and calcium ions, resulting in the depolarisation and
excitation of the muscle cell, thereby producing a muscular contraction. </p>

<p class=MsoNormal style='text-align:justify;text-indent:36.0pt'>The activation
of neuronal nicotinic AChRs also causes the movement of cations through the
opening of an ion channel, with the influx of calcium ions affecting the
release of neurotransmitters.<span style="mso-spacerun: yes">  </span><span
lang=EN style='mso-ansi-language:EN'>Nicotinic AChRs on a postganglionic neuron
are responsible for the initial fast depolarisation of that neuron.</span><span
style="mso-spacerun: yes">  </span><span lang=EN style='mso-ansi-language:EN'>However,
the subsequent hyperpolarisation and slow depolarisation, which represent the
recovery of the postganglionic neuron from stimulation, are mediated by muscarinic
AChR types M2 and M1, respectively. <span style="mso-spacerun: yes"> </span></span>The
binding of nicotine can activate nicotinic AChRs, modifying the neurons in two
ways:<span style="mso-spacerun: yes">  </span>the depolarisation of the membrane
through the movement of cations results in an excitation of the neuron, while
the influx of calcium acts through intracellular cascades affect the regulation
of certain genes and the release of neurotransmitters.</p>

<p class=MsoNormal style='text-align:justify'><span style='mso-tab-count:1'>            </span>Nicotinic
AChRs are composed of five types of subunits: <span style="mso-spacerun:
yes"> </span>alpha (<span style='font-family:Symbol'>a</span>1-<span
style='font-family:Symbol'>a</span>10), beta (<span style='font-family:Symbol'>b</span>2-<span
style='font-family:Symbol'>b</span>5), delta, epsilon and gamma.<span
style="mso-spacerun: yes">  </span>These subunits are found in different
combinations in different types of nicotinic AChRs:<span style="mso-spacerun:
yes">  </span></p>

<p class=MsoNormal style='text-align:justify'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<p class=MsoNormal style='margin-left:84.0pt;text-align:justify;text-indent:
-18.0pt;mso-list:l0 level1 lfo1;tab-stops:list 84.0pt'><![if !supportLists]><span
style='font-family:Wingdings'>Ø<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><![endif]>Muscle nicotinic AChRs (adult neuromuscular junction):<span
style="mso-spacerun: yes">  </span><span style='font-family:Symbol'>a</span>1-<span
style='font-family:Symbol'>e</span>-<span style='font-family:Symbol'>a</span>1-<span
style='font-family:Symbol'>b</span>1-<span style='font-family:Symbol'>d</span> </p>

<p class=MsoNormal style='margin-left:84.0pt;text-align:justify;text-indent:
-18.0pt;mso-list:l0 level1 lfo1;tab-stops:list 84.0pt'><![if !supportLists]><span
style='font-family:Wingdings'>Ø<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><![endif]>Muscle nicotinic AChRs (foetal extrajunctional):<span
style="mso-spacerun: yes">  </span><span style='font-family:Symbol'>a</span>1-<span
style='font-family:Symbol'>g</span>-<span style='font-family:Symbol'>a</span>1-<span
style='font-family:Symbol'>b</span>1-<span style='font-family:Symbol'>d</span></p>

<p class=MsoNormal style='margin-left:84.0pt;text-align:justify;text-indent:
-18.0pt;mso-list:l0 level1 lfo1;tab-stops:list 84.0pt'><![if !supportLists]><span
style='font-family:Wingdings'>Ø<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><![endif]>Neuronal nicotinic AChRs (CNS, PNS and developing
muscle):<span style="mso-spacerun: yes">  </span>(<span style='font-family:
Symbol'>a</span>7)5</p>

<p class=MsoNormal style='margin-left:84.0pt;text-align:justify;text-indent:
-18.0pt;mso-list:l0 level1 lfo1;tab-stops:list 84.0pt'><![if !supportLists]><span
style='font-family:Wingdings'>Ø<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><![endif]>Neuronal and autonomic nicotinic AChRs (ganglion): <span
style="mso-spacerun: yes"> </span><span style='font-family:Symbol'>a</span>3-<span
style='font-family:Symbol'>b</span>4-<span style='font-family:Symbol'>a</span>3-<span
style='font-family:Symbol'>b</span>4-<span style='font-family:Symbol'>b</span>4
and <span style='font-family:Symbol'>a</span>3-<span style='font-family:Symbol'>b</span>2-<span
style='font-family:Symbol'>a</span>3-<span style='font-family:Symbol'>b</span>4-<span
style='font-family:Symbol'>a</span>5</p>

<p class=MsoNormal style='margin-left:84.0pt;text-align:justify;text-indent:
-18.0pt;mso-list:l0 level1 lfo1;tab-stops:list 84.0pt'><![if !supportLists]><span
style='font-family:Wingdings'>Ø<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><![endif]>Neuronal and autonomic nicotinic AChRs (brain): <span
style="mso-spacerun: yes"> </span><span style='font-family:Symbol'>a</span>4-<span
style='font-family:Symbol'>b</span>2-<span style='font-family:Symbol'>a</span>4-<span
style='font-family:Symbol'>b</span>2-<span style='font-family:Symbol'>b</span>2</p>

<p class=MsoNormal style='margin-left:84.0pt;text-align:justify;text-indent:
-18.0pt;mso-list:l0 level1 lfo1;tab-stops:list 84.0pt'><![if !supportLists]><span
style='font-family:Wingdings'>Ø<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><![endif]>Epithelial and neuronal nicotinic AChRs (cochlea hair
cells): <span style="mso-spacerun: yes"> </span>(<span style='font-family:Symbol'>a</span>9)5</p>

<p class=MsoNormal style='text-align:justify'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<p class=MsoNormal style='text-align:justify'>Theses receptors span the
membrane, containing extracellular, transmembrane and cytoplasmic domains, the
latter being the most variable.<span style="mso-spacerun: yes">  </span>Nicotinic
receptors are always pentamers, with the subunits arranged symmetrically around
a central receptor channel. <span style="mso-spacerun: yes"> </span>The
receptors always contain two or more alpha subunits, which are critical in
acetylcholine binding.<span style="mso-spacerun: yes">  </span>The
acetylcholine-binding site is comprised of a dimer formed by the alpha subunits
(principal component) plus an adjacent subunit (complementary component), where
binding to both sites is required for the channel to open.<span
style="mso-spacerun: yes">  </span></p>

<p class=MsoNormal style='text-align:justify;text-indent:36.0pt'>Neurotoxins
frequently target the acetylcholine-binding site, reversibly blocking the opening
of the ion channel and formation of a pore, thereby preventing cations from
passing through.<span style="mso-spacerun: yes">  </span>Neuronal nicotinic
AChRs have been divided into two main groups based on their sensitivity to the snake
venom toxin <span style='font-family:Symbol'>a</span>-bungarotoxin (‘<a
href="http://www.ebi.ac.uk/interpro/potm/2004_6/Page1.htm"
title="Protein of the Month">Snake Venom: Bungarotoxins</a>’).<span
style="mso-spacerun: yes">  </span>The <span style='font-family:Symbol'>a</span>-bungarotoxin-sensitive
receptors are homomeric, containing <span style='font-family:Symbol'>a</span>7
or <span style='font-family:Symbol'>a</span>9, and are found primarily in pre-
and post-synaptic neurons and in developing muscle.<span style="mso-spacerun:
yes">  </span>The <span style='font-family:Symbol'>a</span>-bungarotoxin-insensitive
receptors are heteromeric, containing combinations of <span style='font-family:
Symbol'>a</span>2-<span style='font-family:Symbol'>a6 </span>and<span
style='font-family:Symbol'> b2-b4,</span> and which often modulate the release
of other transmitters.</p>

<p class=MsoNormal style='text-align:justify'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<h2 align=center style='text-align:center'><span style='font-style:normal'>Next:<span
style="mso-spacerun: yes">  </span><a href="Page3.htm">What InterPro Tells Us</a><o:p></o:p></span></h2>

<h2 align=center style='text-align:center'><span style='font-style:normal'>Previous:<span
style="mso-spacerun: yes">  </span><a href="Page1.htm">Neurotransmitters,
Chemical Signals</a><o:p></o:p></span></h2>

<p class=MsoNormal><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<p class=MsoNormal><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

</div>

</body>

</html>
